RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 19.15
-0.45 (-2.30%)
At close: Apr 24, 2026
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 248.49 million as of April 24, 2026. Its market cap has decreased by -2.29% in one year.
Market Cap
248.49M
Enterprise Value
603.22M
Revenue
219.71M
Ranking
n/a
PE Ratio
11.68
Stock Price
19.15
Market Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 248.49M, a decrease of -60.70%. That is a compound annual growth rate of -18.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 248.49M | 13.65% |
| Dec 31, 2025 | 218.65M | -11.78% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.03B |
| TCI GENE | 1.02B |
| NatureWise Biotech & Medicals | 916.55M |
| Neith | 793.51M |
| BioLASCO Taiwan | 759.40M |
| SynCore Biotechnology Co.,Ltd | 687.47M |
| Vectorite Biomedical | 652.19M |
| TaiwanJ Pharmaceuticals | 640.98M |